London researchers discover a novel method to diagnose long COVID
Researchers at Lawson Health Research Institute have found that patients with post-COVID-19 condition (long COVID) have unique biomarkers in their blood. The team is now working on developing a first of its kind blood test that could be used to diagnose long COVID. The discovery could also lead to new therapeutics for this condition.
Every day, hospital-based research in London, Ontario changes the lives of people around the world. Through close proximity to patients, scientists in the hospital can identify challenges and develop solutions effectively and then deliver them to care faster than anywhere else.
Lawson Health Research Institute has been driving innovation and helping to transform health care. Taking a “bench to bedside” approach to medical research, researchers focus their efforts on the development of new knowledge that can be applied directly to patient care. The fast pace of scientific discovery makes medical research an exciting place to be. Learn more about our current studies and how you can be a part of new groundbreaking research.